Tracer Biotechnologies
PrivateLast Round
Series A
Dec 19, 2024
Total Funding Raised
$10M
Company Overview
Tracer Biotechnologies is a biotechnology company that has developed a platform for ultrasensitive circulating tumor DNA (ctDNA) monitoring to detect cancer, measure treatment response, and track recurrence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tracer Biotechnologies Comparables
Compare Tracer Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CareDx | 77% | |
| NeoGenomics Inc | 75% | |
| Veracyte | 74% |
Tracer Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 19, 2024 |
Tracer Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Great Oaks Venture Capital | Series A |
| Impatient Ventures | Series A |
| Quiet Ventures | Series A |
| Exor | Series A |
| Pareto Holdings | Series A |
| Quiet Capital | Series A |
| Caffeinated Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2026
Monthly visitors grew 4231% MoM, from 36 to 1.6K.
- Jun 3, 2025
Developing blood-based MRD tests for solid tumors in partnership with QIAGEN.
Tracer Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tracer Biotechnologies's valuation, stock price, and market status.
Is Tracer Biotechnologies a public or private company?
Tracer Biotechnologies is a private company.
What is the current stock price of Tracer Biotechnologies?
Tracer Biotechnologies is a private company with no public stock price. No recent secondary market data is available.
How much is Tracer Biotechnologies worth (valuation)?
Valuation information for Tracer Biotechnologies is not publicly available.
Can I buy Tracer Biotechnologies stock?
Tracer Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tracer Biotechnologies's last funding round?
Tracer Biotechnologies's most recent funding round was Series A on December 19, 2024.
Who are the main investors in Tracer Biotechnologies?
Key investors in Tracer Biotechnologies include Great Oaks Venture Capital, Impatient Ventures, Quiet Ventures, Exor, Pareto Holdings.
Will Tracer Biotechnologies IPO soon?
No public IPO plans have been announced for Tracer Biotechnologies.
How can I track Tracer Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tracer Biotechnologies's secondary market activity and sign up for updates.